Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Barratt Redrow delivers profit beat, but outlook still cautious

(Sharecast News) - Housebuilder Barratt Redrow delivered annual profits ahead of forecasts despite completions missing its initial guidance range, but pointed to ongoing market challenges and additional uncertainties ahead of the upcoming Budget. Chief executive David Thomas pointed to "limited growth in FY26", with private homebuyer confidence still "fragile given the continuing affordability challenges".

He said that, while the long-term sector fundamentals remain compelling, "it is vital that government policy is focused on reforming the planning system, removing barriers to investment and supporting purchasers, particularly first-time buyers, if the sector is to build the homes the country needs".

Adjusted pre-tax profit totalled £591.6m over the 12 months to 29 June, up 26.8% year-on-year and ahead of the £582.8m consensus estimate, helped by margin improvement and £20m of cost synergies around double the figure initially forecast.

Total home completions were up 18.3% at 16,565, though below the 16,800-17,200 guidance range given at its half-year results in February. However, revenues still surged 33.8% year-on-year to £5.58bn.

Barratt Redrow declared a final dividend of 12.1p, lifting the total dividend by 8.6% to 17.6p per share, compared with the 16.8p expected by analysts.

Looking ahead, the net private weekly reservation rate was broadly flat on last year at 0.55, while forward sales totalled 10,350 homes, down from 10,398, but at a value of £3.14bn, up from £3.02bn the year before.

The company expects to deliver total home completions of 17,200-17,800 over the current financial year.

"This also assumes a normal autumn selling season, our current expectation, however the extended period through to the Budget and related uncertainties around general taxation and that applicable to housing, has introduced additional risk," the company said.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.